In the SCALE trial, patients receiving liraglutide lost an average 5.6 kg (~12 lbs) more than patients receiving placebo, which translated to a 5.4% body weight loss over the course of 56 weeks (NCT01272219)
Such changes are not possible with infant formula
Aim to drink water throughout the day, especially before and after meals
Development of GLP-1 Drugs Decades after the discovery of the natural hormone, there are now several available GLP-1 drugsor GLP-1 receptor agoniststhat can be used to treat diabetes, obesity, and other conditions
Women may experience more week-to-week variation due to menstrual cycle effects on water retention and appetite
Indian GLP-1 Analogues Market Trends The Indian GLP-1 analogues market is expanding quickly, driven by the growing prevalence of obesity and type 2 diabetes in the nation, as well as increased knowledge of cutting-edge treatment options